VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
CELG-RI
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
CELG-RIBristol-Myers Squibb Company Ce
$0.09$188M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksCELG-RIQuarterly Financials

Bristol-Myers Squibb Company Ce (CELG-RI) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Bristol-Myers Squibb Company Ce (CELG-RI) quarterly income statement — complete revenue, gross profit & net income history

CELG-RI Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue11.49B12.5B12.22B12.27B11.2B12.34B11.89B12.2B11.87B11.48B10.97B11.23B11.34B11.41B11.22B11.89B11.65B11.98B11.62B11.7B
Revenue Growth %2.57%1.3%2.77%0.56%-5.6%7.54%8.44%8.69%4.66%0.62%-2.25%-5.56%-2.67%-4.83%-3.49%1.57%5.19%8.29%10.28%15.54%
Cost of Goods Sold3.42B4.22B4.16B4.2B3.86B4.92B5.28B3.27B2.93B2.75B2.51B2.88B2.57B2.59B2.35B2.72B2.47B2.36B2.29B2.45B
COGS % of Revenue29.78%33.76%34%34.22%34.47%39.85%44.36%26.78%24.71%23.92%22.85%25.62%22.63%22.73%20.98%22.88%21.21%19.66%19.71%20.95%
Gross Profit8.07B8.28B8.07B8.07B7.34B7.42B6.62B8.93B8.93B8.73B8.46B8.35B8.77B8.81B8.87B9.17B9.18B9.63B9.33B9.25B
Gross Margin %70.22%66.24%66%65.78%65.53%60.15%55.64%73.22%75.29%76.08%77.15%74.38%77.37%77.27%79.02%77.12%78.79%80.34%80.29%79.05%
Gross Profit Growth %9.92%11.54%21.9%-9.67%-17.83%-14.98%-21.78%6.99%1.85%-0.92%-4.57%-8.91%-4.42%-8.47%-5.01%-0.91%11.48%18.03%16.11%24.51%
Operating Expenses4.29B4.65B4.22B3.95B3.82B4.89B4.36B7.24B7.42B6.83B4.25B6.45B6.34B7.12B6.77B6.53B6.51B7.38B7.31B6.91B
OpEx % of Revenue37.36%37.19%34.54%32.22%34.1%39.65%36.64%59.36%62.53%59.5%38.71%57.45%55.91%62.41%60.31%54.89%55.87%61.56%62.92%59.02%
Selling, General & Admin1.62B2.09B1.79B1.69B1.58B2.1B1.98B1.93B2.37B2.07B2B1.93B1.76B2.27B1.93B1.79B1.83B2.35B1.79B1.88B
SG&A % of Revenue14.07%16.7%14.63%13.78%14.13%17.06%16.68%15.8%19.95%18.06%18.27%17.23%15.54%19.87%17.2%15.03%15.72%19.64%15.38%16.08%
Research & Development2.24B2.56B2.43B2.26B2.24B2.79B2.37B2.9B2.69B2.48B2.24B2.26B2.32B2.51B2.42B2.32B2.26B2.61B2.98B2.48B
R&D % of Revenue19.48%20.48%19.91%18.44%19.96%22.59%19.96%23.76%22.71%21.59%20.45%20.11%20.47%22.01%21.55%19.53%19.4%21.75%25.64%21.17%
Other Operating Expenses1000K0000001000K1000K1000K01000K1000K1000K1000K1000K1000K1000K1000K1000K
Operating Income3.78B3.63B3.85B4.12B3.52B2.53B2.29B1.69B1.51B1.9B4.21B1.9B2.43B1.69B2.1B2.64B2.67B2.25B2.02B2.34B
Operating Margin %32.87%29.05%31.46%33.56%31.43%20.51%19.24%13.86%12.76%16.58%38.44%16.93%21.45%14.85%18.71%22.23%22.91%18.78%17.37%20.03%
Operating Income Growth %7.24%43.5%68.05%143.47%132.56%33%-45.72%-11.05%-37.75%12.34%100.81%-28.05%-8.88%-24.74%3.96%12.71%45.53%368.3%50.45%163.08%
EBITDA3.78B4.66B4.87B5.15B4.55B4.4B4.88B4.29B4.05B4.37B6.67B4.33B4.86B4.21B4.69B5.22B5.25B4.83B4.75B5.06B
EBITDA Margin %32.87%37.31%39.85%41.94%40.61%35.65%41.04%35.14%34.1%38.05%60.79%38.6%42.88%36.95%41.78%43.96%45.1%40.3%40.83%43.2%
EBITDA Growth %-16.99%6%-0.18%20.04%12.43%0.76%-26.79%-1.06%-16.77%3.61%42.22%-17.07%-7.46%-12.73%-1.24%3.34%16.68%160.94%18.74%46.59%
D&A (Non-Cash Add-back)01.03B1.03B1.03B1.03B1.87B2.59B2.6B2.53B2.46B2.45B2.43B2.43B2.52B2.59B2.58B2.58B2.58B2.73B2.71B
EBIT3.78B3.63B3.85B4.12B3.52B671M2.18B1.81B-11.09B1.99B2.42B2.14B3.06B2.15B2.51B2.27B2.01B2.18B2.48B1.88B
Net Interest Income-307M-284M-319M-346M-356M-496M-505M-521M-425M-316M-280M-282M-288M-294M-299M-313M-326M-323M-328M-330M
Interest Income104M148M161M139M138M000000000000000
Interest Expense411M432M480M485M494M496M505M521M425M316M280M282M288M294M299M313M326M323M328M330M
Other Income/Expense-536M-2.16B-731M-2.34B-550M-2.36B-612M-405M-13.03B-229M-2.08B-42M338M165M110M-684M-982M-393M138M-791M
Pretax Income3.24B1.47B3.11B1.77B2.97B175M1.68B1.29B-11.52B1.67B2.14B1.86B2.77B1.86B2.21B1.96B1.69B1.86B2.16B1.55B
Pretax Margin %28.2%11.76%25.48%14.45%26.52%1.42%14.09%10.54%-97.06%14.59%19.49%16.56%24.43%16.3%19.69%16.47%14.48%15.5%18.56%13.27%
Income Tax561M384M919M460M509M99M461M-398M392M-88M203M-218M503M-166M601M529M404M-514M605M492M
Effective Tax Rate %17.31%26.12%29.51%25.94%17.13%56.57%27.51%-30.95%-3.4%-5.26%9.5%-11.73%18.16%-8.93%27.21%27.02%23.95%-27.66%28.05%31.68%
Net Income2.68B1.09B2.2B1.31B2.46B72M1.21B1.68B-11.91B1.76B1.93B2.07B2.26B2.02B1.61B1.42B1.28B2.37B1.55B1.05B
Net Margin %23.3%8.69%18.01%10.68%21.93%0.58%10.18%13.77%-100.39%15.35%17.58%18.47%19.95%17.73%14.32%11.95%10.97%19.79%13.3%9.01%
Net Income Growth %9%1409.72%81.75%-22.02%120.62%-95.91%-37.19%-18.96%-626.57%-12.86%20.05%45.88%77%-14.76%3.88%34.69%-36.76%123.66%-17.41%1341.18%
Net Income (Continuing)2.68B1.09B2.19B1.31B2.46B76M1.22B1.68B-11.91B1.76B1.93B2.08B2.27B2.02B1.61B1.43B1.28B2.37B1.55B1.06B
Discontinued Operations00000000000000000000
Minority Interest34M33M48M54M59M53M58M54M58M55M64M57M62M57M63M61M65M60M71M66M
EPS (Diluted)1.310.531.080.641.200.040.600.83-5.890.870.930.991.070.950.750.660.591.070.690.47
EPS Growth %9.17%1401.42%80%-22.89%120.37%-95.94%-35.48%-16.16%-650.47%-8.42%24%50%81.36%-11.21%8.7%40.43%-33.71%124.04%-15.85%1350%
EPS (Basic)1.310.531.080.641.210.040.600.83-5.890.870.940.991.080.960.750.670.601.100.700.47
Diluted Shares Outstanding2.05B2.04B2.04B2.04B2.04B2.04B2.03B2.03B2.02B2.03B2.06B2.1B2.11B2.12B2.15B2.15B2.16B2.22B2.24B2.25B
Basic Shares Outstanding2.04B2.04B2.04B2.04B2.03B2.03B2.03B2.03B2.02B2.03B2.06B2.09B2.1B2.11B2.13B2.13B2.15B2.15B2.22B2.23B
Dividend Payout Ratio-116.1%57.38%96.34%51.22%1691.67%100.41%72.44%-65.83%61.77%57.74%52.87%56.63%71.86%80.93%92.72%46.33%70.5%104.17%